FY2017 Earnings Roundup - 1: Major Japan Makers Braced for Gloomier Year Ahead at Home, See 4.4% Dip

By Reiji Anasako Japan drug makers squeaked out growth in the year ended March 2018, helped by their overseas operations, according to a Jiho tally . Yet, their revenue in the home market floundered on major patent expiries, with Japan...read more